Insider trades

Syntone Ventures, 10% Owner of Outlook Therapeutics OTLK, has filed 1 purchase and 0 sales on the open market. The latest trade was on 24/04/15.

Syntone Ventures

10% Owner
First filing
24/04/17
Trades
2 trades
Buys / sales
1 / 0
12-month net buying
No record
Last trade
24/04/15

Trading activity

Transactions

Trade type
Open-market buy24/04/1524/04/17714,286 shIn footnoteNo stated value+72.1%